Further evidence for the role of MET in autism susceptibility

Neuroscience Research

Volumn 68, Issue 2, 2010, Pages 137-141

  Thanseem, Ismail ^a   Nakamura, Kazuhiko ^a   Miyachi, Taishi ^a   Toyota, Tomoko ^b   Yamada, Satoru ^c   Tsujii, Masatsugu ^a,d   Tsuchiya, Kenji J ^a   Anitha, Ayyappan ^a   Iwayama, Yoshimi ^b   Yamada, Kazuo ^b   Hattori, Eiji ^b   Matsuzaki, Hideo ^e   Matsumoto, Kaori ^a   Iwata, Yasuhide ^a   Suzuki, Katsuaki ^a   Suda, Shiro ^a   Kawai, Masayoshi ^a   Sugihara, Gen Ichi ^a   Takebayashi, Kiyokazu ^a   Takei, Noriyoshi ^a   Ichikawa, Hironobu ^c   Sugiyama, Toshiro ^f   Yoshikawa, Takeo ^b   Mori, Norio ^a   more..

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c TOKYO METROPOLITAN CHILDREN'S MEDICAL CENTER   (Japan)

^d CHUKYO UNIVERSITY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

^f AICHI CHILDREN'S HEALTH AND MEDICAL CENTER   (Japan)

Author keywords

Association study; Autism spectrum disorder; Candidate gene; Hepatocyte growth factor receptor; Neurodevelopment; Single nucleotide polymorphism

Indexed keywords

SCATTER FACTOR RECEPTOR;

ARTICLE; AUTISM; CHILD; DISEASE PREDISPOSITION; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, GROWTH FACTOR;

EID: 77956272123     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2010.06.014     Document Type: Article

References (28)

1. Abrahams B.S., Geschwind D.H. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 2008, 9:341-355.
2. Akimoto M., Baba A., Ikeda-Matsuo Y., Yamada M.K., Itamura R., Nishiyama N., Ikegaya Y., Matsuki N. Hepatocyte growth factor as an enhancer of NMDA currents and synaptic plasticity in the hippocampus. Neuroscience 2004, 128:155-162.
3. APA Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4th edn.
4. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. MET, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4:915-925.
5. Campbell D.B., Sutcliffe J.S., Ebert P.J., Militerni R., Bravaccio C., Trillo S., Elia M., Schneider C., Melmed R., Sacco R., Persico A.M., Levitt P. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16834-16839.
6. Campbell D.B., D'Oronzio R., Garbett K., Ebert P.J., Mirnics K., Levitt P., Persico A.M. Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann. Neurol. 2007, 62:243-250.
7. Campbell D.B., Buie T.M., Winter H., Bauman M., Sutcliffe J.S., Perrin J.M., Levitt P. Distinct genetic risk based on association of MET in families with co-occurring autism and gastrointestinal conditions. Pediatrics 2009, 123:1018-1024.
8. Campbell D.B., Warren D., Sutcliffe J.S., Lee E.B., Levitt P. Association of MET with social and communication phenotypes in individuals with autism spectrum disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 153B:438-446.
9. Emanuele E., Lossano C., Politi P., Barale F. Pioglitazone as a therapeutic agent in autistic spectrum disorder. Med. Hypotheses 2007, 69:699.
10. Geschwind D.H., Sowinski J., Lord C., Iversen P., Shestack J., Jones P., Ducat L., Spence S.J. The autism genetic resource exchange: a resource for the study of autism and related neuropsychiatric conditions. Am. J. Hum. Genet. 2001, 69:463-466.
11. Geschwind D.H., Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 2007, 17:103-111.
12. Gong R., Rifai A., Dworkin L.D. Activation of PI3K-Akt-GSK3beta pathway mediates hepatocyte growth factor inhibition of RANTES expression in renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 2005, 330:27-33.
13. Harada A., Teng J., Takei Y., Oguchi K., Hirokawa N. MAP2 is required for dendrite elongation, PKA anchoring in dendrites, and proper PKA signal transduction. J. Cell Biol. 2002, 158:541-549.
14. Kuehn B.M. CDC: autism spectrum disorders common. JAMA 2007, 297:940.
15. Levitt P., Eagleson K.L., Powell E.M. Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci. 2004, 27:400-406.
16. Lim C.S., Walikonis R.S. Hepatocyte growth factor and c-MET promote dendritic maturation during hippocampal neuron differentiation via the Akt pathway. Cell. Signal. 2007, 20:825-835.
17. Lord C., Cook E.H., Leventhal B.L., Amaral D.G. Autism spectrum disorders. Neuron 2000, 28:355-363.
18. Lord C., Rutter M., Le Couteur A. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J. Autism Dev. Disord. 1994, 24:659-685.
19. Losh M., Sullivan P.F., Trembath D., Piven J. Current developments in the genetics of autism: from phenome to genome. J. Neuropathol. Exp. Neurol. 2008, 67:829-837.
20. Powell E.M., Campbell D.B., Stanwood G.D., Davis C., Noebels J.L., Levitt P. Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. J. Neurosci. 2003, 23:622-631.
21. Ranade K., Chang M.S., Ting C.T., Pei D., Hsiao C.F., Olivier M., Pesich R., Hebert J., Chen Y.D., Dzau V.J., Curb D., Olshen R., Risch N., Cox D.R., Botstein D. High-throughput genotyping with single nucleotide polymorphisms. Genome Res. 2001, 11:1262-1268.
22. Rubenstein J.L., Merzenich M.M. Model of autism: increased ratio of excitation/inhibition in key neural systems. Genes Brain Behav. 2003, 2:255-267.
23. Sánchez C., Pérez M., Avila J. GSK3beta-mediated phosphorylation of the microtubule-associated protein 2C (MAP2C) prevents microtubule bundling. Eur. J. Cell Biol. 2000, 79:252-260.
24. Sousa I., Clark T.G., Toma C., Kobayashi K., Choma M., Holt R., Sykes N.H., Lamb J.A., Bailey A.J., Battaglia A., Maestrini E., Monaco A.P. MET and autism susceptibility: family and case-control studies. Eur. J. Hum. Genet. 2008, 17:749-758.
25. State M.W. A surprising METamorphosis: autism genetics finds a common functional variant. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:16621-16622.
26. Steyaert J.G., De la Marche W. What's new in autism?. Eur. J. Pediatr. 2008, 167:1091-1101.
27. Sugihara G., Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., Suzuki K., Suda S., Matsuzaki H., Kawai M., Minabe Y., Yagi A., Takei N., Sugiyama T., Mori N. Decreased serum levels of hepatocyte growth factor in male adults with high-functioning autism. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:412-415.
28. Tyndall S.J., Walikonis R.S. The receptor tyrosine kinase MET and its ligand hepatocyte growth factor are clustered at excitatory synapses and can enhance clustering of synaptic proteins. Cell Cycle 2006, 5:1560-1568.